Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • TrumpRx
  • Pharmacy Discount Coupons
  • Hantavirus
  • PFAS in Water
  • Tear Gas and ICE Raids

WHAT'S NEW

  • TrumpRx
  • Pharmacy Discount Coupons
  • Hantavirus
  • PFAS in Water
  • Tear Gas and ICE Raids

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, Mar 23 2018

Full Issue

Americans Think Pharma Has More Clout In Washington Than NRA Or Wall Street

A poll finds that while Americans are concerned about drug prices, many don't have confidence that the current administration will be able to fix high prices.

Stat: Most Americans Believe Pharma Has More Sway In Washington Than The NRA Or Wall Street 

Most Americans believe the pharmaceutical industry has too much influence in Washington and wields more clout in the nation’s capital than Wall Street or the National Rifle Association, a new poll finds. Specifically, 72 percent say drug makers hold sway over Washington, compared with 69 percent who believe Wall Street is too influential and 52 percent who report that the NRA has too much pull. Health insurers clocked in at 66 percent. Only large corporations ranked higher, at 76 percent, according to the poll by the Kaiser Family Foundation. (Silverman, 3/23)

Kaiser Health News: Poll: Americans Aghast Over Drug Costs But Aren’t Holding Their Breath For A Fix

Drug prices are among the few areas of health policy where Americans seem to find consensus. Eighty percent of people said they think drug prices are too high, and both Democrats (65 percent) and Republicans (74 percent) agreed the industry has too much sway over lawmakers. (Bluth, 3/23)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Thursday, May 7
  • Wednesday, May 6
  • Tuesday, May 5
  • Monday, May 4
  • Friday, May 1
  • Thursday, April 30
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF